Literature DB >> 12854081

Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro.

Willem A Hanekom1, Megan Mendillo, Claudia Manca, Patrick A J Haslett, M Ruby Siddiqui, Clifton Barry, Gilla Kaplan.   

Abstract

To induce effector immunity, dendritic cells (DCs) must differentiate into fully mature cells. We show that, after human monocyte-derived DCs were infected with virulent Mycobacterium tuberculosis, up-regulation of cellular-surface maturation markers was minimal and reversible. In the presence of a potent stimulus for maturation (tumor necrosis factor [TNF]-alpha, interleukin [IL]-1beta, and prostaglandin E2 [PGE2]), M. tuberculosis inhibited phenotypic DC maturation. M. tuberculosis-infected DCs had an impaired ability to induce allogeneic lymphoproliferation and activated autologous memory CD4+ and CD8+ T cells optimally only in the presence of TNF-alpha, IL-1beta, and PGE2. Thus, virulent M. tuberculosis inhibits phenotypic and functional maturation of human monocyte-derived DCs. This mechanism, which has been described elsewhere for various viruses and for the virulent mycobacterium M. leprae, may be a novel mechanism that this pathogen uses to evade the host's immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854081     DOI: 10.1086/376451

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Virulence-dependent induction of interleukin-10-producing-tolerogenic dendritic cells by Mycobacterium tuberculosis impedes optimal T helper type 1 proliferation.

Authors:  Hongmin Kim; Kee Woong Kwon; Woo Sik Kim; Sung Jae Shin
Journal:  Immunology       Date:  2017-02-28       Impact factor: 7.397

2.  Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1.

Authors:  Ranjna Madan-Lala; Jonathan Kevin Sia; Rebecca King; Toidi Adekambi; Leticia Monin; Shabaana A Khader; Bali Pulendran; Jyothi Rengarajan
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

3.  Enterobacter sakazakii targets DC-SIGN to induce immunosuppressive responses in dendritic cells by modulating MAPKs.

Authors:  Rahul Mittal; Silvia Bulgheresi; Claudia Emami; Nemani V Prasadarao
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

Review 4.  Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.

Authors:  A Baena; S A Porcelli
Journal:  Tissue Antigens       Date:  2009-06-25

5.  Mycobacterium tuberculosis GroEL2 Modulates Dendritic Cell Responses.

Authors:  Jonathan Kevin Sia; Erica Bizzell; Maria Georgieva; Ranjna Madan-Lala; Jyothi Rengarajan
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

Review 6.  The role of dendritic cells in mycobacterium-induced granulomas.

Authors:  Heidi A Schreiber; Matyas Sandor
Journal:  Immunol Lett       Date:  2010-01-04       Impact factor: 3.685

Review 7.  Disruption of immune regulation by microbial pathogens and resulting chronic inflammation.

Authors:  Kenneth Barth; Daniel G Remick; Caroline A Genco
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

8.  Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase.

Authors:  Nisheeth Agarwal; Gyanu Lamichhane; Radhika Gupta; Scott Nolan; William R Bishai
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

9.  Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses.

Authors:  Xisheng Wang; Peter F Barnes; Fangfang Huang; Ivana B Alvarez; Pierre F Neuenschwander; David R Sherman; Buka Samten
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

10.  Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model.

Authors:  Heidi A Schreiber; Paul D Hulseberg; JangEun Lee; Jozsef Prechl; Peter Barta; Nora Szlavik; Jeffrey S Harding; Zsuzsanna Fabry; Matyas Sandor
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.